Cigna Corporation (NYSE:CI) insider Matthew G. Manders sold 24,357 shares of Cigna Corporation stock in a transaction on Friday, July 21st. The stock was sold at an average price of $175.01, for a total transaction of $4,262,718.57. Following the completion of the transaction, the insider now directly owns 46,256 shares in the company, valued at $8,095,262.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Shares of Cigna Corporation (CI) opened at 173.81 on Wednesday. Cigna Corporation has a one year low of $115.03 and a one year high of $175.80. The company has a market cap of $44.50 billion, a PE ratio of 23.21 and a beta of 0.46. The stock’s 50 day moving average is $169.58 and its 200-day moving average is $156.35.
Cigna Corporation (NYSE:CI) last announced its quarterly earnings results on Friday, May 5th. The health services provider reported $2.77 EPS for the quarter, beating the consensus estimate of $2.44 by $0.33. The firm had revenue of $10.39 billion for the quarter, compared to analyst estimates of $10.11 billion. Cigna Corporation had a return on equity of 16.07% and a net margin of 6.53%. The business’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter last year, the firm posted $2.46 earnings per share. Equities research analysts expect that Cigna Corporation will post $9.79 earnings per share for the current year.
WARNING: This story was originally posted by Transcript Daily and is the property of of Transcript Daily. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States and international trademark & copyright law. The correct version of this story can be viewed at https://transcriptdaily.com/2017/07/26/matthew-g-manders-sells-24357-shares-of-cigna-corporation-ci-stock.html.
CI has been the topic of a number of research analyst reports. Deutsche Bank AG initiated coverage on shares of Cigna Corporation in a research report on Wednesday, April 5th. They set a “buy” rating and a $172.00 price objective on the stock. Zacks Investment Research downgraded shares of Cigna Corporation from a “hold” rating to a “sell” rating in a research report on Wednesday, April 5th. Credit Suisse Group initiated coverage on shares of Cigna Corporation in a research report on Monday, June 12th. They set an “outperform” rating and a $185.00 price objective on the stock. Jefferies Group LLC reissued a “buy” rating and set a $183.00 price objective (up from $178.00) on shares of Cigna Corporation in a research report on Friday, May 5th. Finally, Stifel Nicolaus boosted their price objective on shares of Cigna Corporation from $170.00 to $175.00 and gave the company a “buy” rating in a research report on Friday, May 5th. Two research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company’s stock. Cigna Corporation currently has an average rating of “Buy” and a consensus price target of $176.33.
Several institutional investors have recently made changes to their positions in CI. American Beacon Advisors Inc. purchased a new position in shares of Cigna Corporation during the first quarter valued at approximately $102,000. Baystate Wealth Management LLC raised its position in shares of Cigna Corporation by 436.1% in the first quarter. Baystate Wealth Management LLC now owns 772 shares of the health services provider’s stock valued at $116,000 after buying an additional 628 shares in the last quarter. Founders Capital Management purchased a new position in shares of Cigna Corporation during the first quarter valued at approximately $117,000. Mckinley Capital Management LLC Delaware purchased a new position in shares of Cigna Corporation during the first quarter valued at approximately $122,000. Finally, Guardian Life Insurance Co. of America raised its position in shares of Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock valued at $145,000 after buying an additional 7 shares in the last quarter. Hedge funds and other institutional investors own 86.85% of the company’s stock.
Cigna Corporation Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.